Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
AtriCure, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue $330.4 million, EPS approximately $1.10 to $1.12. Guidance initiated.
- Period
- the fourth quarter and full year ended December 31, 2022
- Revenue
- $330.4 million
- EPS
- approximately $1.10 to $1.12
- Guidance
- initiated
- Result
- preliminary results
Exact text from the filing
Preliminary, unaudited revenue for fourth quarter 2022 is expected to be approximately $88.0 million, reflecting growth of approximately 20% over the fourth quarter of 2021 (21% on a constant currency basis).
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
AtriCure, Inc. reported the fourth quarter and full year ended December 31, 2022 results: revenue $330.4 million, EPS approximately $1.10 to $1.12. Guidance initiated.
- Period
- the fourth quarter and full year ended December 31, 2022
- Revenue
- $330.4 million
- EPS
- approximately $1.10 to $1.12
- Guidance
- initiated
- Result
- preliminary results
Exact text from the filing
Preliminary, unaudited revenue for full year 2022 is expected to be $330.4 million, reflecting growth of approximately 20% over full year 2021 (22% on a constant currency basis).
View on SEC.gov